1. Market Research
  2. > Kiadis Pharma B.V. - Product Pipeline Review - 2013

Kiadis Pharma B.V. - Product Pipeline Review - 2013

  • July 2013
  • -
  • Global Markets Direct
  • -
  • 20 pages

Kiadis Pharma B.V. - Product Pipeline Review - 2013

Summary

Global Markets Direct’s pharmaceuticals report, “Kiadis Pharma B.V. - Product Pipeline Review - 2013” provides data on the Kiadis Pharma B.V.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Kiadis Pharma B.V.’s corporate website, SEC filings, investor presentations and featured press releases, both from Kiadis Pharma B.V. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Kiadis Pharma B.V. - Brief Kiadis Pharma B.V. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Kiadis Pharma B.V. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Kiadis Pharma B.V. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Kiadis Pharma B.V.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Kiadis Pharma B.V.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Kiadis Pharma B.V. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Kiadis Pharma B.V.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Kiadis Pharma B.V..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Kiadis Pharma B.V. and identify potential opportunities in those areas.

Table Of Contents

Kiadis Pharma B.V. - Product Pipeline Review - 2013
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Kiadis Pharma B.V. Snapshot 4
Kiadis Pharma B.V. Overview 4
Key Information 4
Key Facts 4
Kiadis Pharma B.V. - Research and Development Overview 5
Key Therapeutic Areas 5
Kiadis Pharma B.V. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Kiadis Pharma B.V. - Pipeline Products Glance 9
Kiadis Pharma B.V. Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Phase I Products/Combination Treatment Modalities 10
Kiadis Pharma B.V. - Drug Profiles 11
ATIR 11
Product Description 11
Mechanism of Action 11
RandD Progress 11
Reviroc 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
Rhitol 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
Kiadis Pharma B.V. - Pipeline Analysis 14
Kiadis Pharma B.V. - Pipeline Products by Therapeutic Class 14
Kiadis Pharma B.V. - Pipeline Products by Route of Administration 15
Kiadis Pharma B.V. - Recent Pipeline Updates 16
Kiadis Pharma B.V. - Dormant Projects 17
Kiadis Pharma B.V. - Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
Coverage 19
Secondary Research 19
Primary Research 19
Expert Panel Validation 19
Contact Us 20
Disclaimer 20

List of Tables

Kiadis Pharma B.V., Key Information 4
Kiadis Pharma B.V., Key Facts 4
Kiadis Pharma B.V. - Pipeline by Indication, 2013 6
Kiadis Pharma B.V. - Pipeline by Stage of Development, 2013 7
Kiadis Pharma B.V. - Monotherapy Products in Pipeline, 2013 8
Kiadis Pharma B.V. - Phase II, 2013 9
Kiadis Pharma B.V. - Phase I, 2013 10
Kiadis Pharma B.V. - Pipeline By Therapeutic Class, 2013 14
Kiadis Pharma B.V. - Pipeline By Route of Administration, 2013 15
Kiadis Pharma B.V. - Recent Pipeline Updates, 2013 16
Kiadis Pharma B.V. - Dormant Developmental Projects,2013 17

List of Figures

Kiadis Pharma B.V. - Pipeline by Indication, 2013 6
Kiadis Pharma B.V. - Pipeline by Stage of Development, 2013 7
Kiadis Pharma B.V. - Monotherapy Products in Pipeline, 2013 8
Kiadis Pharma B.V. - Pipeline By Therapeutic Class, 2013 14
Kiadis Pharma B.V. - Pipeline By Route of Administration, 2013 15

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.